Pierre Mordant

4.2k total citations
169 papers, 2.2k citations indexed

About

Pierre Mordant is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Pierre Mordant has authored 169 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pulmonary and Respiratory Medicine, 88 papers in Surgery and 40 papers in Oncology. Recurrent topics in Pierre Mordant's work include Transplantation: Methods and Outcomes (41 papers), Lung Cancer Diagnosis and Treatment (39 papers) and Lung Cancer Treatments and Mutations (27 papers). Pierre Mordant is often cited by papers focused on Transplantation: Methods and Outcomes (41 papers), Lung Cancer Diagnosis and Treatment (39 papers) and Lung Cancer Treatments and Mutations (27 papers). Pierre Mordant collaborates with scholars based in France, Réunion and Canada. Pierre Mordant's co-authors include Françoise Le Pimpec‐Barthes, Marc Riquet, Antoine M. Dujon, Alex Arame, Yves Castier, Éric Deutsch, Yohann Loriot, C. Pricopi, Christophe Foucault and Jean‐Charles Soria and has published in prestigious journals such as Circulation, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Pierre Mordant

151 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pierre Mordant France	26	1000	752	486	392	266	169	2.2k
Clemens Aigner Germany	32	1.6k 1.6×	1.6k 2.2×	632 1.3×	719 1.8×	440 1.7×	250	3.5k
Ross M. Bremner United States	28	715 0.7×	1.3k 1.8×	422 0.9×	273 0.7×	564 2.1×	164	2.5k
Vincent Donckier Belgium	31	513 0.5×	1.3k 1.8×	628 1.3×	173 0.4×	234 0.9×	138	3.2k
Isabelle Opitz Switzerland	32	2.5k 2.5×	826 1.1×	631 1.3×	316 0.8×	431 1.6×	249	3.7k
Thomas J. Hugh Australia	25	539 0.5×	891 1.2×	900 1.9×	117 0.3×	281 1.1×	135	1.9k
Alla M. Rozenblit United States	29	1.3k 1.3×	1.1k 1.5×	286 0.6×	108 0.3×	208 0.8×	81	2.5k
Gilbert Massard France	37	2.6k 2.6×	1.7k 2.3×	956 2.0×	215 0.5×	322 1.2×	222	4.2k
Jin Gu Lee South Korea	27	1.2k 1.2×	858 1.1×	607 1.2×	165 0.4×	272 1.0×	149	2.4k
B. Padovani France	22	942 0.9×	1.0k 1.3×	342 0.7×	107 0.3×	95 0.4×	97	2.1k
Mathew H. Chung United States	23	414 0.4×	883 1.2×	751 1.5×	83 0.2×	133 0.5×	74	1.8k

Countries citing papers authored by Pierre Mordant

Since Specialization

Citations

This map shows the geographic impact of Pierre Mordant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Mordant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Mordant more than expected).

Fields of papers citing papers by Pierre Mordant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Mordant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Mordant. The network helps show where Pierre Mordant may publish in the future.

Co-authorship network of co-authors of Pierre Mordant

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Mordant. A scholar is included among the top collaborators of Pierre Mordant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Mordant. Pierre Mordant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Atchade, Enora, Nathalie Zappella, Sylvain Jean‐Baptiste, et al.. (2025). Time on the waiting list is an independent risk factor for day-90 mortality after lung transplantation. Anaesthesia Critical Care & Pain Medicine. 44(2). 101499–101499.

Archer, Gabrielle, A. Justet, Madeleine Jaillet, et al.. (2024). FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 211(3). 486–498. 4 indexed citations

Roussel, Arnaud, Édouard Sage, Pierre‐Emmanuel Falcoz, et al.. (2024). Survival outcomes following urgent lung transplantation in France and the USA. Thorax. 79(8). 745–753.

Blanc, Thomas, Carmen Capito, Edward Lambert, et al.. (2024). Impact of robotic-assisted surgery on length of hospital stay in Paris public hospitals: a retrospective analysis. Journal of Robotic Surgery. 18(1). 332–332. 5 indexed citations

Etienne, Harry, Jimmy Mullaert, Pierre Cerceau, et al.. (2024). How safe is lung transplantation in patients of 65 years or older? A single-center retrospective cohort. Respiratory Medicine and Research. 86. 101139–101139.

Picard, C., Martine Reynaud‐Gaubert, Ana Nieves, et al.. (2023). Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis. Respirology. 29(1). 71–79. 2 indexed citations

Fogel, Paul, et al.. (2023). Preventing Acute Limb Ischemia during VA-ECMO—In Silico Analysis of Physical Parameters Associated with Lower Limb Perfusion. Journal of Clinical Medicine. 12(18). 6049–6049. 2 indexed citations

Grall, Nathalie, Vincent Bunel, C. Godet, et al.. (2023). Risk of Bronchial Complications After Lung Transplantation With Respiratory Corynebacteria. Results From a Monocenter Retrospective Cohort Study. Transplant International. 36. 10942–10942. 1 indexed citations

Wolf, Julien De, Anne Olland, Pierre‐Emmanuel Falcoz, et al.. (2023). Controlled donation after circulatory death lung transplantation: Results of the French protocol including in situ abdominal normothermic regional perfusion and ex vivo lung perfusion. The Journal of Heart and Lung Transplantation. 42(8). 1093–1100. 10 indexed citations

10.

Tanaka, Sébastien, Christian de Tymowski, Alexy Tran‐Dinh, et al.. (2023). Low HDL-Cholesterol Concentrations in Lung Transplant Candidates are Strongly Associated With One-Year Mortality After Lung Transplantation. Transplant International. 36. 10841–10841. 1 indexed citations

11.

Nakajima, Daisuke, Yui Watanabe, Akihiro Ohsumi, et al.. (2019). Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation. The Journal of Heart and Lung Transplantation. 38(11). 1214–1223. 63 indexed citations

12.

Legras, Antoine, Anne Tallet, Audrey Didelot, et al.. (2018). Clinical and molecular characteristics of unicentric mediastinal Castleman disease. Journal of Thoracic Disease. 10(4). 2079–2088. 5 indexed citations

13.

Brayer, Stéphanie, Audrey Joannes, Madeleine Jaillet, et al.. (2017). The pro-apoptotic BAX protein influences cell growth and differentiation from the nucleus in healthy interphasic cells. Cell Cycle. 16(21). 2108–2118. 19 indexed citations

14.

Ghalayini, Mohamed, P. Brun, Pascal Augustin, et al.. (2016). Esmolol Corrects Severe Hypoxemia in Patients with Femoro-Femoral Venoarterial Extracorporeal Life Support for Lung Transplantation. Journal of ExtraCorporeal Technology. 48(3). 113–121. 5 indexed citations

15.

Dupin, Clairelyne, Elodie Lhuillier, S. Létuvé, et al.. (2016). Inhibition of T Cell Alloreactivity by Bronchial Epithelium Is Impaired in Lung Transplant Recipients, Through Pathways Involving TGF-β, IL-10 and HLA-G. Transplantation. 101(9). 2192–2199. 6 indexed citations

16.

Bagan, Patrick, Pascal Berna, Florence De Dominicis, et al.. (2012). Nutritional Status and Postoperative Outcome After Pneumonectomy for Lung Cancer. The Annals of Thoracic Surgery. 95(2). 392–396. 55 indexed citations

17.

Beurtheret, Sylvain, Pierre Mordant, Xavier Paolettí, et al.. (2012). Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). European Heart Journal. 34(2). 112–120. 164 indexed citations

18.

Mordant, Pierre, Yohann Loriot, Julien Caldéraro, et al.. (2010). Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination. Molecular Cancer Therapeutics. 9(2). 358–368. 42 indexed citations

19.

Beurtheret, Sylvain, Pierre Mordant, A Pavie, & Pascal Leprince. (2010). Successful weaning of a left ventricular assist device implanted for ischemic heart failure. Interactive Cardiovascular and Thoracic Surgery. 11(4). 507–509. 4 indexed citations

20.

Loriot, Yohann, Pierre Mordant, Éric Deutsch, Ken A. Olaussen, & Jean‐Charles Soria. (2009). Are RAS mutations predictive markers of resistance to standard chemotherapy?. Nature Reviews Clinical Oncology. 6(9). 528–534. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact